Nel ASA's Pivot to Cheaper Electrolyzers Faces Its First Real Test
Published on 08/18/2026 at 09:11 | Redaktion boerse-global.de
The Norwegian hydrogen equipment maker has gone quiet — and for a company whose share price has drifted 45 percent from its May peak, silence can be just as telling as news flow. With Nel ASA's stock hovering at EUR 0.1994, below its 50-day moving average of EUR 0.2090, investors are left weighing a product launch that promises dramatically lower costs against a revenue line that is heading in the wrong direction.
The PA-Series Promise
The centerpiece of Nel's turnaround effort is the PA-Series, a pressurized alkaline electrolyzer platform that the company says can cut capital expenditures for turnkey plants by 40 to 60 percent. That is a substantial claim in a market where cost competitiveness often determines whether projects reach final investment decision. The technology is designed to shrink the physical footprint of electrolyzers while meaningfully reducing upfront costs — a combination Nel hopes will resonate with customers shopping for on-site hydrogen production.
Early signals are encouraging on the order front. Second-quarter intake jumped 224 percent year-on-year to NOK 230 million, lifting the total backlog to NOK 1.2 billion. Management has flagged that initial concrete orders for the PA-Series could land in the coming months, following the platform's launch in May.
A Revenue Picture That Complicates the Narrative
The order momentum, however, sits awkwardly against the income statement. Revenue fell 12 percent in the same quarter to NOK 153.4 million, with the bottom line additionally squeezed by a NOK 70 million settlement payment to industrial gas producer Iwatani Corporation. That one-off charge weighed directly on EBITDA and helps explain why the market has not greeted the PA-Series launch with more enthusiasm.
Should investors sell immediately? Or is it worth buying Nel ASA?
The stock's recent drift reflects this mixed picture. After slipping 1.5 percent on the day, the shares have now lost 2.7 percent over the past week, though they remain up 5.6 percent year-to-date. The relative strength index sits at 44.4, suggesting neither overbought nor oversold conditions — a technical snapshot that matches the broader sense of a market waiting for clarity.
Analyst Caution and a Crowded Field
J.P. Morgan trimmed its price target on Nel to NOK 1.80 from NOK 2.90 in early August, maintaining a "Neutral" rating. The bank cited a revised view on dynamics within the alkaline electrolyzer segment — precisely the arena where Nel is now staking its claim with the PA-Series.
The competitive backdrop is only getting more intense. Future Market Insights projects the global hydrogen electrolyzer market will reach USD 8.81 billion by 2036, with on-site installations expected to drive roughly 58 percent of demand in 2026. That is the segment Nel is targeting, but it is also where established players and well-funded newcomers are converging.
What Could Break the Stalemate
The EU's recent decision to support the PA-Series manufacturing line, announced about two weeks ago, provided a modest lift — the stock has gained 2.6 percent since that news broke. But with that catalyst now priced in, the market is looking for something more concrete.
The company's stated roadmap calls for expanding manufacturing capacity to 500 megawatts by the end of 2026, then doubling that to one gigawatt the following year. Those are ambitious targets that will require sustained order flow to justify.
The next scheduled checkpoint arrives on October 21, when Nel reports third-quarter results. Between now and then, order intake becomes the key metric to watch — the question being whether the second-quarter surge represents the beginning of a durable trend or a one-off spike. For a stock trading closer to its February low than its May high, the answer will likely determine whether the current sideways drift gives way to something more decisive.
Ad
Nel ASA Stock: New Analysis - 18 August
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
